Page last updated: 2024-10-22

amiodarone and Angiogenesis, Pathologic

amiodarone has been researched along with Angiogenesis, Pathologic in 1 studies

Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.

Research Excerpts

ExcerptRelevanceReference
"Amiodarone is an anti-arrhythmic drug that was approved by the US Food and Drug Administration (FDA) in 1985."1.56Low dose amiodarone reduces tumor growth and angiogenesis. ( Benny, O; Birsner, AE; Brill-Karniely, Y; D'Amato, RJ; Fluksman, A; Karsch-Bluman, A; Steinberg, E; Tischenko, K; Zemmour, C, 2020)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Steinberg, E1
Fluksman, A1
Zemmour, C1
Tischenko, K1
Karsch-Bluman, A1
Brill-Karniely, Y1
Birsner, AE1
D'Amato, RJ1
Benny, O1

Other Studies

1 other study available for amiodarone and Angiogenesis, Pathologic

ArticleYear
Low dose amiodarone reduces tumor growth and angiogenesis.
    Scientific reports, 2020, 10-22, Volume: 10, Issue:1

    Topics: Amiodarone; Animals; Apoptosis; Cell Movement; Cell Proliferation; Dose-Response Relationship, Drug;

2020